YELLOW III Study | Effects of PCSK9 inhibitors on coronary plaque | Dr. Annapoorna Kini Published 2023-03-08 Download video MP4 360p Recommendations 08:02 ACC 23: Effect of Evolocumab on Coronary Plaque Morphology: The YELLOW III Study 07:27 Ultimate DAPT Trial: Dr. Gregg W Stone Discusses Results with Dr. Karol Quelal (ACC.24, Atlanta, GA) 58:49 Pushing the Envelope with PCSK9-Twenty Years of Progress 01:12 YELLOW III Trial - Effects of aggressive lipid management on coronary plaque | Dr. Annapoorna Kini 13:08 Oral PCSK9 Inhibitor - Safety and Efficacy in Hypercholesterolemia with Dr. Ballantyne 58:08 The Cholesterol Wars: Identifying Patients Who Would Most Benefit from PCSK9 Inhibitors (Part 1) 06:15 PCSK9 Inhibitors: Single Agent or With Ezetimibe? 28:21 Time to Treat the Vulnerable Plaques - Dr. Gregg Stone 13:33 my journey with tikosyn dofetilide 05:41 What is PCSK9 and how PCSK9 inhibitors work? (Mechanism of action) 52:04 A Real World Approach to LDL cholesterol using PCSK9 inhibitors, October 5 2018 53:13 Diagnosing and Treating Hyperlipidemia: Recent Evidence and the Role of PCSK9-targeted Therapies 17:16 Vitamin B3 is the NEW Holy Grail of Glaucoma Treatment. Here’s Why. 47:30 Approaches to Lowering LDL-C. What is new in 2021 for Statin Intolerant Patient? 58:10 Cardiac CT and Plaque Assessment: More than a diagnosis. Similar videos 06:02 PCSK9 Inhibitors and CV Risk 00:44 What is a PCSK9 inhibitor? #pcsk9 #Repatha #Praluent #inclisarin #cholesterol 04:24 Repatha: PCSK9 inhibitor USE/Development & Very Low LDL Levels 03:11 NADIR ALI F | PSK9 Inhibitors TRIAL: cuts LDL by 60%, but RAISES MORTALITY!! 09:48 App Technology Enhancing Clinical Practice - Dr. Annapoorna S Kini 23:18 Professor Kausik Ray - PCSK9 inhibition – have we reached the limits of lipid lowering and outcome? 21:44 Intravascular Imaging and Yellow III Trial - Yuliya Vengrenyuk, PhD 07:51 Efficacy and Safety of PCSK9 Inhibitors 08:22 Is Coronary Plaque Regression Possible? 1:04:56 Intertwined Roles of PCSK9 in Lipoprotein Metabolism and Inflammation - Weekly Research Conference 04:29 PCSK9 Inhibitors - How do they work? (Pharmacology, Indications, Side effects) 04:17 ESC 23: LIBerate-HeFH: Novel PCSK9-Inhibitor in Heterozygous Familial Hypercholesterolemia More results